Key result
COVID-19 vaccination linked to rare myocarditis responding well to symptomatic treatment and NSAIDs.
Why the study?
Cases of myocarditis have been encountered in several individuals after receiving the COVID-19 vaccine, necessitating description and review.
Case Report (n=4)
Answers are grounded in this paper and cite their sources.
Myocarditis cases after COVID-19 vaccination warrant clinical vigilance; leaves open questions of causality and incidence pending larger studies.
Many efforts have been undertaken to develop a successful vaccine to contain the catastrophe since the COVID-19 outbreak. Early in December 2020, the SARS-CoV-2 vaccine program was initiated, and it significantly reduced transmission and mortality. However, there are cases of cardiac complications like myocarditis that have been encountered in several individuals after administrating the COVID-19 vaccine. Therefore, this present work aims to describe four cases of Myocarditis in the existing literature review. A literature search was carried out using Scopus, Science Direct, PubMed, and other renowned databases for high-quality recent individualized case reports of individuals having myocarditis after receiving the vaccine, research papers, case series, and review articles with no language restriction. The findings from the four cases and rigorous literature review revealed that myocarditis is one of the adverse reactions after COVID-19 vaccination which comes with initial symptoms of chest pain and fever which can further execrate if ignored. However, the use of symptomatic relief and anti-inflammatory non-steroidal drugs have4 been noted to be effective in managing myocarditis induced by COVID-19 Vaccinations.
No takes yet. Share an insight, caveat, or question.
Renuka et al. (2022) conducted a case report in Myocarditis (n=4). COVID-19 Vaccination was evaluated on Myocarditis as an adverse reaction. COVID-19 vaccination was associated with myocarditis presenting with chest pain and fever in four cases, which were effectively managed with symptomatic relief and non-steroidal anti-inflammatory drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: